Author

Máté Erdö

Observed name: M Erdö

Observed institution: Isotopen Technologien München (Germany)

OpenAlex ID: A5076778876

Genetic profiling analysis design of well-differentiated aggressive grade 2 and 3 gastroenteropancreatic neuroendocrine tumors in the phase III randomized controlled COMPOSE trial.

2023 · Thorvardur Ragnar Halfdanarson, Jaume Capdevila, et al. · Journal of Clinical Oncology · 1

Works count: 4

Citation count: 1

H-index: 1

I10-index: